Massachusetts General Hospital
Associate Professor of Pathology
Harvard Medical School
We are in the process of identifying molecular and genetic changes of urologic cancers that correlate with the cancer disease behaviors, both clinically and pathologically. The long-term goal of these studies is to develop new diagnostic methods and therapeutic regiments for these cancers.
See details at the Wu Lab.
PublicationsBibliography of Chin-Lee Wu via PubMed
A team led by MGH researchers has identified a genetic signature that may reflect the risk of tumor recurrence or spread in men surgically treated for prostate cancer. If confirmed, the genetic risk index also may help distinguish tumors that require aggressive treatment from those that can safely be monitored.